A UCSD center that's been facilitating Covid-19 clinical research gets $55M from NIH to boost translational work
A team at the University of California San Diego that’s been facilitating studies on the frontlines of Covid-19 has received a $54.7 million grant from the NIH to bind basic research with clinical care even more tightly together.
Every year the 1,000 faculty and staff at the Altman Clinical and Translational Research Institute partner with UCSD Health to help run 250 trials — including recent trials investigating “an antiviral drug, an arthritis drug and a medication for hypertension” as treatments for the coronavirus infection.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.